USA – MCM-Related Guidance by Date

FDA develops guidance to provide its policy perspectives and recommendations on a wide variety of topics. The guidance documents below may be of special interest to existing or prospective medical countermeasure (MCM) sponsors, and other stakeholders, including state, tribal, local and territorial public health preparedness personnel.

This page lists MCM-related guidance and industry information updates by date issued, and is not intended as a comprehensive list…